search Search
search Search

Events

Events

Don't miss out on the latest congress updates and reserve your place at our stand today!
Missed the event or want to revisit the key takeaways from the speakers? No problem! Our event review section is your go-to for valuable insights.

Upcoming events

30.09.2026 Milan, Italy

EASD Symposium 2026, Milan

Join us at EASD 2026 in Milan! Visit us at booth H.01 to meet our experts and discover the latest developments around myLoop powered by CamAPS FX.

Read more...

Event Reviews

ATTD 2026 in Barcelona

mylife Diabetes Care symposium at ATTD 2026 highlights clinical insights on personalising AID therapy across different populations. 

Watch the recording now to discover the key lever for personalising automated insulin delivery.

Read more...

ISPAD 2025 in Montreal

At the annual ISPAD 2025 conference in Montreal, we presented our AID solution myLoop powered by CamAPS FX, designed and licensed for use in adolescents. Dr. Julia Ware and Dr Martin Tauschmann demonstrated how children managing their type 1 diabetes as well as personal glucose target and cared for with myLoop at every stage of their childhood. 

Read more...

Active Lives, Safer Choices: Exercise & Diabetes with myLoop powered by CamAPS FX

Webinar Review: Active Lives, Safer Choices: Exercise & Diabetes with myLoop powered by CamAPS FX

In this expert-led session, Prof. Othmar Moser shared practical insights on exercising safely with type 1 diabetes. The webinar highlighted how myLoop powered by CamAPS FX helps users stay active with confidence through smart insulin management.

Read more...

EASD 2025 in Vienna

At the 61st EASD 2025, a live session led by Prof. Othmar Moser demonstrated how people with type 1 diabetes can train safely using myLoop powered by CamAPS FX. Three athletes performed different types of exercise, illustrating how the system keeps glucose levels stable and supports a better quality of life.

Read more...

Starting Strong: Setting Up myLoop in Very Young Children

Webinar Review: Starting Strong: Setting Up myLoop in Very Young Children"

In this insightful session, pediatric diabetes expert Prof. Sabine E. Hofer shared practical strategies and clinical experience on introducing AID therapy in very young children. The webinar highlighted how early use of myLoop can positively transform care in this sensitive age group.

Read more...

Confident Transitions: Introducing myLoop powered by CamAPS FX for Pregnancy Care

Webinar Review: The "Confident transitions Introducing myLoop powered by CamAPS FX for pregnancy care" webinar with Prof. Beato-Vibora and Núria Alonso-Carril explored how myLoop powered by CamAPS FX, enhances diabetes management during pregnancy.

Read more...

Event Reviews

ISPAD 2025 in Montreal

At the annual ISPAD 2025 conference in Montreal, we presented our AID solution myLoop powered by CamAPS FX, designed and licensed for use in adolescents. Dr. Julia Ware and Dr Martin Tauschmann demonstrated how children managing their type 1 diabetes as well as personal glucose target and cared for with myLoop at every stage of their childhood. 

Read more...

EASD 2025 in Vienna

At the 61st EASD 2025, a live session led by Prof. Othmar Moser demonstrated how people with type 1 diabetes can train safely using mylife Loop powered by CamAPS FX. Three athletes performed different types of exercise, illustrating how the system keeps glucose levels stable and supports a better quality of life.

Read more...

Successful Participation at ATTD 2025 in Amsterdam

Our workshop at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2025) was a great success. Titled “Optimising Outcomes at Every Life Stage: The Transformative Impact of myLoop in Type 1 Diabetes,” the session brought together leading experts to explore how myLoop, powered by CamAPS FX, enhances diabetes management across different life stages.

Read more...

Successful Participation at ISPAD 2024

At the ISPAD's 50th annual Conference in Lisbon, we presented our AID solution, myLoop powered by CamAPS FX and successfully hosted a practical workshop about "Automated Insulin Delivery with CamAPS FX to Manage Type 1 Diabetes with Practical Insights."

Read more...

EASD 2024 in Madrid

At the 60th annual EASD 2024 conference in Madrid, we presented our AID solution myLoop powered by CamAPS FX, the first hybrid closed-loop algorithm designed and licensed for use in planning or during pregnancy.

Read more...

Related Content

You may also be interested in ...

information
Product Information
Powered by CamAPS FX, myLoop is indicated for children aged one year and older and for use in pregnancy.
Learn More
bulb
Educational material
Discover recent study data and how myLoop powered by CamAPS FX can make a difference for your patients with T1D.
Discover more
download
Resources
Explore factsheets, downloads, and scientific publications to support your practice and advance patient care.
Explore more

1 Lee TTM, et al. Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes. N Engl J Med. 2023 Oct 26;389(17):1566-1578. doi: 10.1056/NEJMoa2303911.

Disclaimer

mylife, YpsoPump, myLoop, Orbit and myOrbit are registered trademarks of mylife Diabetes Care AG or of its affiliates. Other trademarks are the property of their respective owners. The product images are for illustrative purposes only.

CamDiab Ltd. is the legal manufacturer of CamAPS. CamAPS is used with YpsoPump, of which mylife Diabetes Care AG is the legal manufacturer.

CamAPS, CamAPS Liberty and MealAssist are registered trademarks of CamDiab Ltd.

Dexcom and Dexcom G7 are registered trademarks of Dexcom, Inc. in the United States and/or other countries.

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission.

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by mylife Diabetes Care AG or of its affiliates is under license.

iPhone and Apple are trademarks of Apple Inc., registered in the US and other countries and regions.

CamAPS FX with FreeStyle Libre 3, FreeStyle Libre 3 Plus, Dexcom G7 or Glooko®: The innovation described is available in selected countries and expanding to further countries soon. Expansion is contingent upon local regulatory approval.

myLoop with Freestyle Libre3/Libre 3 Plus: The innovations described are available in selected countries and expanding to further countries soon. Expansion is contingent upon local regulatory approval.Insulin pumps and Automated Insulin Delivery (AID) systems can improve glucose management but do not remove the risk of diabetic ketoacidosis (DKA). Because these systems use only rapid-acting insulin, any interruption in insulin delivery (e.g., infusion-set failure, occlusion, empty reservoir, or device malfunction) can rapidly lead to ketosis and DKA, even if glucose levels are not markedly elevated.Healthcare professionals should ensure that users understand the risk of DKA associated with pump and AID therapy, particularly in situations where insulin delivery may be interrupted. Users should be trained to recognise and troubleshoot delivery issues promptly, know when and how to check for ketones and seek urgent medical assistance. Advise to always keep a reliable backup method of insulin delivery available.This information is provided for general educational purposes and is intended for healthcare professionals. It does not replace individual clinical judgement or patient-specific medical advice.

information
For safety information on mentioned products, see

link www.mylife-diabetescare.com/safety

mylife Diabetes Care Ltd.1 Park CourtRiccall RoadEscrickYO19 6EDUnited Kingdom

Free Call 0344 856 7820 (UK)Free Call 1800 911 522 (ROI)F +44 844 507 0443

info@mylife-diabetescare.co.uk

© 2026 mylife Diabetes Care AG